RLMD
Relmada Therapeutics Inc
3.50$
-3.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -1.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -1.6% | -17.0% | – | – | -43.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.2% | +93.1% | -62.4% | -10.2% | -9.1% | +1,006.0% | -42.5% | +48.1% | -11.5% | +1.5% | +140.6% | -38.5% | -13.8% | +177.2% | +18.1% | +111.1% | +32.6% | -5.9% | +23.6% | +96.1% | -25.7% | -1.0% | +23.6% | -1.2% | -12.0% | -41.0% | -13.4% | -23.9% | +41.1% | -9.8% | -19.4% | +4.0% | -1.3% | +8.6% | -76.4% | +43.2% | +100.0% | +0.2% | +3.8% | – | |
| – | +2.4% | +39.8% | -10.8% | -49.0% | +60.2% | -32.4% | +10.0% | +1.9% | +124.5% | -35.8% | -25.2% | +70.7% | +61.4% | +86.1% | +36.0% | -20.0% | +1.2% | +39.3% | +8.9% | -5.2% | +2.9% | +49.1% | +9.9% | -43.8% | +44.2% | +3.9% | 0.0% | -0.4% | -1.3% | -19.8% | -16.4% | +46.5% | -31.9% | -22.4% | +18.1% | -15.0% | +94.9% | -7.2% | -41.8% | – | |
| – | -5.0% | +48.6% | -21.9% | -45.0% | +48.5% | +75.0% | -24.3% | +24.9% | +44.3% | -22.3% | +53.1% | -10.4% | +23.1% | +118.5% | +27.9% | +34.7% | +21.8% | +7.1% | +18.1% | +61.2% | -19.9% | +12.0% | +18.8% | -14.9% | -0.1% | -27.3% | -7.6% | -12.8% | +18.2% | -14.3% | -18.1% | +22.3% | -17.1% | -4.5% | -43.9% | +1.0% | +96.9% | -4.3% | -22.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -55.6% | +25.1% | +65,861.9% | -99.2% | +12,266.0% | +27.3% | +58.7% | +3.2% | -78.5% | -88.6% | +3,980.1% | -94.2% | -2.0% | +997.4% | -0.9% | -10.1% | -38.3% | +87.3% | -23.1% | -7.8% | -34.2% | +640.0% | +285.1% | -87.8% | +11.2% | +141.7% | -25.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -655.0% | – | – | – | -1,019.3% | – | +257.6% | -31.8% | +276.6% | – | – | – | – | – | -334.5% | – | – | – | – | -430.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,411.7% | – | +22.0% | -67.4% | -4,296.6% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.